Rarely do investors have the opportunity to invest in a pharmaceutical company doing clinical trials where the drug awaiting regulatory approval has been in use for decades. The US government has already spent hundreds of millions of dollars researching the safety and efficacy of psychedelics.
Then Richard Nixon, alarmed at the association between LSD and opposition to the Vietnam War, ignored the scientific research and declared